| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
61,398,000 |
| Market
Cap: |
283.66(M) |
| Last
Volume: |
821,939 |
Avg
Vol: |
693,736 |
| 52
Week Range: |
$3.38 - $6.95 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 803 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
121,098 |
121,098 |
148,134 |
388,157 |
| Total Sell Value |
$513,345 |
$513,345 |
$684,141 |
$2,735,436 |
| Total People Sold |
5 |
5 |
6 |
8 |
| Total Sell Transactions |
10 |
10 |
14 |
33 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Birznieks Gunther |
SVP, Business Development |
• – – |
2021-03-01 |
4 |
S |
$18.66 |
$71,744 |
D/D |
(3,845) |
188,328 |
|
-10% |
|
| Moran Kevin Patrick |
SVP, CFO & Treasurer |
• – – |
2021-03-01 |
4 |
S |
$18.57 |
$61,780 |
D/D |
(3,327) |
107,470 |
|
-10% |
|
| Williams Timothy |
SVP & General Counsel |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
112,056 |
|
- |
|
| Birznieks Gunther |
SVP, Business Development |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
192,173 |
|
- |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
1,418,747 |
|
- |
|
| Wijkstrom Joakim |
SVP, Chief Marketing Officer |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
25,800 |
82,090 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-02-24 |
4 |
S |
$20.01 |
$460,033 |
D/D |
(22,986) |
100,800 |
|
-0% |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-02-24 |
4 |
OE |
$12.27 |
$276,063 |
D/D |
22,499 |
123,786 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
25,800 |
101,287 |
|
- |
|
| Moran Kevin Patrick |
SVP, CFO & Treasurer |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
110,797 |
|
- |
|
| Dugan Richard W |
Director |
– • – |
2021-02-16 |
4 |
S |
$18.54 |
$106,663 |
D/D |
(5,754) |
54,887 |
|
-11% |
|
| Dugan Richard W |
Director |
– • – |
2021-02-16 |
4 |
OE |
$7.11 |
$106,650 |
D/D |
15,000 |
60,641 |
|
- |
|
| Watkins Thomas |
Director |
– • – |
2021-02-16 |
4 |
S |
$18.54 |
$107,856 |
D/D |
(5,818) |
49,505 |
|
-11% |
|
| Watkins Thomas |
Director |
– • – |
2021-02-16 |
4 |
OE |
$7.11 |
$106,650 |
D/D |
15,000 |
55,323 |
|
- |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2020-12-15 |
4 |
S |
$13.00 |
$508,844 |
D/D |
(39,150) |
1,303,747 |
|
-27% |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2020-12-15 |
4 |
OE |
$8.75 |
$408,301 |
D/D |
46,663 |
1,342,897 |
|
- |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2020-12-14 |
4 |
S |
$13.19 |
$673,306 |
D/D |
(51,049) |
1,296,234 |
|
-30% |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2020-12-14 |
4 |
OE |
$8.75 |
$538,300 |
D/D |
61,520 |
1,347,283 |
|
- |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2020-12-11 |
4 |
S |
$12.88 |
$451,360 |
D/D |
(35,053) |
1,285,763 |
|
-33% |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2020-12-11 |
4 |
OE |
$8.75 |
$365,899 |
D/D |
41,817 |
1,320,816 |
|
- |
|
| Wijkstrom Joakim |
SVP, Chief Marketing Officer |
• – – |
2020-08-20 |
4 |
S |
$11.08 |
$41,109 |
D/D |
(3,710) |
56,290 |
|
-21% |
|
| Williams Timothy |
SVP & General Counsel |
• – – |
2020-08-14 |
4 |
S |
$11.81 |
$43,526 |
D/D |
(3,684) |
79,356 |
|
-12% |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2020-08-12 |
4 |
S |
$11.81 |
$85,018 |
D/D |
(7,200) |
75,487 |
|
-13% |
|
| Moran Kevin Patrick |
SVP, CFO & Treasurer |
• – – |
2020-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,344 |
78,097 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2020-07-27 |
4 |
S |
$10.62 |
$77,631 |
D/D |
(7,313) |
82,687 |
|
-22% |
|
549 Records found
|
|
Page 5 of 22 |
|
|
0.14 (3.12%) 
